Keyword: Bayer

News

EU may seek more Bayer-Monsanto Concessions

20.12.2017 - The European Commission is apparently not entirely satisfied with the concessions Bayer and Monsanto have offered in exchange for approval of their proposed $66 billion merger...

News

Bayer Combines Pharma R&D in one Unit

13.12.2017 - From Jan. 1, 2018, Bayer will streamline its strategic pharmaceutical research and development activities and combine them under a single unit covering the therapeutic areas...

News

First Loss for Bayer and J&J in Xarelto Suits

12.12.2017 - In the fourth of three lawsuits heard by US courts over the risks of the blockbuster blood thinner Xarelto to date, a jury in Philadelphia, Pennsylvania, last week ordered Bayer...

Markets & Companies

The German Capital Region

24.11.2017 -

The German capital region is one of the leading life sciences and healthcare industries centers in the world. A total of around 30,000 employees work in more than 500...

News

Novartis and Bayer Warn on NHS Eye Drug Plan

21.11.2017 - European pharmaceutical industry heavyweights Novartis and Bayer are challenging a proposal by parts of the UK’s National Health Service (NHS) to allow patients with wet age...

News

EU’s Glyphosate Vote Fails Yet Again

10.11.2017 - For the second time in two weeks and the sixth time altogether, an EU expert panel has failed to agree on whether to extend the license of the herbicide chemical glyphosate at all...

News

EU Vote on Glyphosate Fails Yet Again

26.10.2017 - The EU has again failed to reach agreement on renewing authorization for use of glyphosate. No formal vote was taken at the Commission meeting on Oct. 25, as an initial round of...

News

Bayer to Sell Selected Crop Science Businesses to BASF

13.10.2017 - In a bid to allay competition fears over its pending purchase of Monsanto, Bayer has agreed to sell selected crop science businesses to BASF for €5.9 billion. The purchase is said...